Tirzepatide (Mounjaro) Posted or Updated on 1 Jul 2025

From 23 June 2025, access to the medication tirzepatide (Mounjaro®) began in England for a small number of patients living with obesity who are at the highest risk of serious health conditions.

In the Black Country, new community-based weight management services are currently being developed to support safe and effective access to this treatment, this means GPs are not yet able to prescribe tirzepatide (Mounjaro®) for weight management in this area.

Please do not contact your GP about tirzepatide at this time. GPs currently cannot prescribe this treatment or refer patients into the new pathway until local services are launched.